z-logo
Premium
PMDA’s Vision for Horizon Scanning of Emerging Technologies Potentially Relevant to the Development of New Medical Products: The Regulatory Challenge
Author(s) -
Shimokawa Masafumi,
Sato Daisaku,
Wakao Rika,
Arai Hiroyuki
Publication year - 2021
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1986
Subject(s) - regulatory agency , agency (philosophy) , emerging technologies , business , health technology , order (exchange) , quality (philosophy) , key (lock) , risk analysis (engineering) , medical care , health care , medicine , computer science , political science , computer security , public administration , finance , economics , economic growth , artificial intelligence , philosophy , epistemology , family medicine
A key goal of regulatory agencies for medical products is to make innovative products available to patients and the medical community in a timely manner in order to improve the quality of public health and health care. Thus, regulators must respond quickly to emerging technologies. It is a horizon scanning method, based on which the Japanese regulatory agency will have the expertise prior to review of forthcoming products of evolving technologies.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here